Stryker Reports Strong Q4 2025 Earnings with Record Growth
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 30 2026
0mins
Should l Buy SYK?
Source: seekingalpha
Stryker Corp (SYK) saw its stock rise by 4.72% as it reached a 20-day high, reflecting strong investor confidence following its recent earnings report.
The company reported an impressive 11% organic sales growth in Q4 2025, surpassing $25 billion in annual sales, driven by strong performance in its Neurocranial, Endoscopy, and Trauma sectors. Adjusted earnings per share reached $4.47, up 11.5% year-over-year, showcasing robust profitability despite external pressures. Furthermore, Stryker's optimistic guidance for 2026, projecting organic sales growth of 8% to 9.5%, reinforces its market leadership and future growth potential.
This strong performance not only highlights Stryker's resilience in the medical device sector but also positions the company favorably for continued growth, as it capitalizes on new product launches and international market opportunities.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SYK?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SYK
Wall Street analysts forecast SYK stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SYK is 430.32 USD with a low forecast of 390.00 USD and a high forecast of 465.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
20 Analyst Rating
17 Buy
3 Hold
0 Sell
Strong Buy
Current: 362.420
Low
390.00
Averages
430.32
High
465.00
Current: 362.420
Low
390.00
Averages
430.32
High
465.00
About SYK
Stryker Corporation is a medical technology company. The Company offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. The Company also offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Stryker Declares Quarterly Dividend of $0.88 per Share
- Quarterly Dividend Announcement: Stryker Corporation has declared a quarterly dividend of $0.88 per share, consistent with previous distributions, indicating stable cash flow and a commitment to shareholder returns, which is likely to bolster investor confidence.
- Dividend Yield: The forward yield stands at 0.98%, reflecting the company's attractiveness in the current market environment, potentially drawing in investors seeking stable income.
- Shareholder Record Date: The dividend will be payable on April 30, with a record date of March 31 and an ex-dividend date also on March 31, ensuring shareholders receive their payouts promptly, which may enhance loyalty towards the company.
- Future Growth Outlook: Stryker projects organic sales growth of 8% to 9.5% for 2026 while advancing margin expansion and new product launches, indicating a proactive strategic positioning in a competitive market landscape.
See More
Apple's Earnings Beat Expectations but Shares Decline
- Apple's Strong Performance: Apple reported a fiscal first-quarter earnings per share of $2.84, exceeding the $2.67 expected by analysts, with revenue hitting $143.76 billion, significantly above the $138.48 billion forecast, driven by robust sales of the iPhone 17 models, despite a 1.3% drop in share price.
- Metals Miners Decline: Shares of Newmont and Freeport-McMoRan fell 9.6% and 7.6%, respectively, primarily due to a decline in gold and silver prices, reflecting market concerns over metal demand, which could impact future investment decisions.
- Chevron's Earnings Beat: Chevron's fourth-quarter adjusted earnings reached $1.52 per share, surpassing the $1.45 consensus from analysts, bolstered by record oil production, leading to a share price increase of over 1%, indicating strong performance in the oil market.
- Deckers' Positive Outlook: Deckers Outdoor's 2026 outlook projects earnings per share between $6.80 and $6.85, with revenue expectations of $5.4 billion to $5.43 billion, both exceeding market expectations, resulting in a 16.1% surge in share price.
See More
Stryker Corp Stock Rises 3.3% Following Increased Annual Profit Outlook
Stock Performance: Stryker Corporation's shares increased by 3.3%.
Profit Forecast: The rise in share price follows the company raising its annual profit forecast.
See More
Wall Street Analysts Adjust Ratings
- Analyst Rating Changes: Top Wall Street analysts have adjusted their ratings on several companies, indicating a shift in market sentiment that could influence investor decisions and market trends.
- Upgrades and Downgrades: While specific upgrades and downgrades are not detailed, such changes typically have a direct impact on the stock prices of the affected companies, prompting investors to pay close attention to these shifts.
- Market Reaction Expectations: Adjustments in analyst ratings may lead to short-term volatility in the stocks involved, and investors should consider these professional insights when contemplating buy or sell actions.
- Investor Decision Impact: As analysts revise their views on stocks, investors may reassess their portfolios, potentially affecting overall market sentiment and liquidity.
See More
Stryker Stock Rises 1.7% in Premarket Trading Following Increased Annual Profit Forecast
Stock Market Movement: Shares of Stryker Corporation increased by 1.7% in pre-market trading.
Profit Forecast Adjustment: The rise in shares follows an upward revision of the company's profit forecast for the fiscal year.
See More
Apple's Earnings Beat Expectations but Shares Decline
- Apple's Strong Performance: Apple reported fiscal first-quarter earnings of $2.84 per share, exceeding the $2.67 expected by analysts, with revenue of $143.76 billion significantly surpassing the $138.48 billion forecast, yet shares fell by 0.6%.
- Chevron's Earnings Beat: Chevron's fourth-quarter adjusted earnings reached $1.52 per share, beating the $1.45 consensus, although revenue of $46.87 billion fell short of expectations, leading to a slight decline in shares.
- Sandisk's Stock Surge: Sandisk's guidance for third-quarter adjusted earnings ranging from $12 to $14 per share far exceeded the FactSet consensus of $5.11, resulting in a 22% increase in stock price.
- Deckers' Positive Outlook: Deckers anticipates earnings between $6.80 and $6.85 per share for 2026, with revenue projected at $5.4 to $5.43 billion, both surpassing analyst expectations, causing a 10.9% rise in shares.
See More
Stryker Declares Quarterly Dividend of $0.88 per Share
- Quarterly Dividend Announcement: Stryker Corporation has declared a quarterly dividend of $0.88 per share, consistent with previous distributions, indicating stable cash flow and a commitment to shareholder returns, which is likely to bolster investor confidence.
- Dividend Yield: The forward yield stands at 0.98%, reflecting the company's attractiveness in the current market environment, potentially drawing in investors seeking stable income.
- Shareholder Record Date: The dividend will be payable on April 30, with a record date of March 31 and an ex-dividend date also on March 31, ensuring shareholders receive their payouts promptly, which may enhance loyalty towards the company.
- Future Growth Outlook: Stryker projects organic sales growth of 8% to 9.5% for 2026 while advancing margin expansion and new product launches, indicating a proactive strategic positioning in a competitive market landscape.
See More
Apple's Earnings Beat Expectations but Shares Decline
- Apple's Strong Performance: Apple reported a fiscal first-quarter earnings per share of $2.84, exceeding the $2.67 expected by analysts, with revenue hitting $143.76 billion, significantly above the $138.48 billion forecast, driven by robust sales of the iPhone 17 models, despite a 1.3% drop in share price.
- Metals Miners Decline: Shares of Newmont and Freeport-McMoRan fell 9.6% and 7.6%, respectively, primarily due to a decline in gold and silver prices, reflecting market concerns over metal demand, which could impact future investment decisions.
- Chevron's Earnings Beat: Chevron's fourth-quarter adjusted earnings reached $1.52 per share, surpassing the $1.45 consensus from analysts, bolstered by record oil production, leading to a share price increase of over 1%, indicating strong performance in the oil market.
- Deckers' Positive Outlook: Deckers Outdoor's 2026 outlook projects earnings per share between $6.80 and $6.85, with revenue expectations of $5.4 billion to $5.43 billion, both exceeding market expectations, resulting in a 16.1% surge in share price.
See More
Stryker Corp Stock Rises 3.3% Following Increased Annual Profit Outlook
Stock Performance: Stryker Corporation's shares increased by 3.3%.
Profit Forecast: The rise in share price follows the company raising its annual profit forecast.
See More
Wall Street Analysts Adjust Ratings
- Analyst Rating Changes: Top Wall Street analysts have adjusted their ratings on several companies, indicating a shift in market sentiment that could influence investor decisions and market trends.
- Upgrades and Downgrades: While specific upgrades and downgrades are not detailed, such changes typically have a direct impact on the stock prices of the affected companies, prompting investors to pay close attention to these shifts.
- Market Reaction Expectations: Adjustments in analyst ratings may lead to short-term volatility in the stocks involved, and investors should consider these professional insights when contemplating buy or sell actions.
- Investor Decision Impact: As analysts revise their views on stocks, investors may reassess their portfolios, potentially affecting overall market sentiment and liquidity.
See More
Stryker Stock Rises 1.7% in Premarket Trading Following Increased Annual Profit Forecast
Stock Market Movement: Shares of Stryker Corporation increased by 1.7% in pre-market trading.
Profit Forecast Adjustment: The rise in shares follows an upward revision of the company's profit forecast for the fiscal year.
See More
Apple's Earnings Beat Expectations but Shares Decline
- Apple's Strong Performance: Apple reported fiscal first-quarter earnings of $2.84 per share, exceeding the $2.67 expected by analysts, with revenue of $143.76 billion significantly surpassing the $138.48 billion forecast, yet shares fell by 0.6%.
- Chevron's Earnings Beat: Chevron's fourth-quarter adjusted earnings reached $1.52 per share, beating the $1.45 consensus, although revenue of $46.87 billion fell short of expectations, leading to a slight decline in shares.
- Sandisk's Stock Surge: Sandisk's guidance for third-quarter adjusted earnings ranging from $12 to $14 per share far exceeded the FactSet consensus of $5.11, resulting in a 22% increase in stock price.
- Deckers' Positive Outlook: Deckers anticipates earnings between $6.80 and $6.85 per share for 2026, with revenue projected at $5.4 to $5.43 billion, both surpassing analyst expectations, causing a 10.9% rise in shares.
See More
